1 Oct 2024
Study of Retinal and Peripapillary Vascular Changes in Newly Diagnosed Acute Leukemic Patients Using Optical Coherence Tomography AngiographyPublisher siteQJM, Retinal and Optic Conditions
UniversitiesAbdelrahman Gaber Salman
Active, last published 2026
In retinal diseases and treatments
Abdelrahman Gaber
Salman
Scholar“Research focused on Retinal Diseases and Treatments and adjacent fields.”
Ain Shams University
Claim Your Profile11
H-index
388
Citations
Abdelrahman has not officially claimed their profile. If you are Abdelrahman, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
bdelrahman Gaber Salman is a researcher working on Retinal Diseases and Treatments. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Abdelrahman's work has been cited 388 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Retinal Diseases and Treatments×14Glaucoma and retinal disorders×8Retinal Imaging and Analysis×7Corneal surgery and disorders×5Ocular Surface and Contact Lens×5
04 · Where I am
Affiliations
Affiliation on published researchAin Shams UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 Jun 2023
Screening of Oral Tamoxifen Ocular Toxicity in Breast Cancer PatientsPublisher siteQJM, Drug-Induced Ocular Toxicity
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Abdelrahman?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you